Ischemic Stroke Clinical Trial
The main objective of this study is to determine the risk factors and etiologies of ischemic stroke in Korean young adults. Both well-documented risk factors and little known life-style related risk factors such as life-style habits, psychological distress including occupational distress, perceived stress and depression will be evaluated by comparison with healthy controls using a structured questionnaire. Secondary objectives are to determine stroke outcomes such as mortality, recurrent vascular events and post-stroke epilepsy in these patients.
All consecutive patients who had their first-ever ischemic stroke symptoms within the
previous month will be asked to enroll in the study. Baseline measurements will be assessed
in all patients. Patients without language problems or life-threatening conditions will be
asked to answer the structured lifestyle questionnaire. Age- and sex-matched controls
without a stroke history will be recruited among patients' friends, relatives and the
care-givers of other patients, and will be requested to complete the same questionnaire.
People who visit hospital for health check-ups may also be included as controls. After the
first assessment, all patients will be followed every 3 months during visits to the
outpatient department or by telephone. Participants will be asked about recurrence of
stroke, occurrence of post-stroke epilepsy, and functional outcomes on the modified Rankin
Scale. In the case of patients who have died, information will be obtained from their last
practitioner or care-giver.
Sample size and power calculation. The sample sizes were calculated based on the frequency
of psychological distress, which is the most interesting potential risk factor for ischemic
stroke in the young. According to a previous report comparing psychological distress in
ischemic stroke patients and healthy controls,8 the frequency of stress was 50.3% in the
ischemic stroke patients and 38.6% in the healthy controls; a difference of 11.7%. To detect
such a difference with a power of 90% and alpha of 0.05 with a drop-out rate of 20%, a
sample size of at least 470 patients and 470 controls will be needed (PASS 13).
Clinical information. Demographic and clinical information will be collected on
admission.The data include age, gender, traditional risk factors for stroke (hypertension,
diabetes, hyperlipidemia, smoking and coronary heart disease), medication history
(anti-hypertensives, anti-diabetics, anti-platelets and statins) and other comorbidities.
Hypertension is defined as previous use of antihypertensive medication, systolic blood
pressure ≥140 mmHg or diastolic BP ≥90 mmHg at discharge, diabetes as previous use of
antidiabetic medication or fasting blood glucose ≥126 mg/dL, and hyperlipidemia as previous
use of lipid-lowering agents, fasting serum total cholesterol ≥240 mg/dL or low-density
lipoprotein ≥160 mg/dL. With regard to cigarette smoking, subjects will be classified as
current, former, or non-smokers. Number of pack-years will be noted for former and current
smokers. History of coronary heart disease is defined as previous angina pectoris,
myocardial infarction, or coronary artery bypass grafting. Patients will also be asked about
any other comorbid diseases.
Stroke characteristics and laboratory investigations. Data on stroke characteristics will be
collected at admission, including symptoms at time of onset and pre-hospital delay. Severity
of stroke will be measured on the National Institutes of Health Stroke Scale (NIHSS) by
physicians certified by the Clinical Research Center for Stroke in Korea. The course of the
disease during admission will be established, including treatments and complications. On
discharge, each case of ischemic stroke will be classified according to the TOAST
classification. Modified Rankin Scale (mRS) and Barthel index scores will also be obtained
at discharge. Laboratory investigations including complete blood cell count, erythrocyte
sedimentation rate, C-reactive protein, urinalysis, urine pregnancy test, serum
electrolytes, liver function test, renal function tests, chest X-ray and electrocardiogram
will be checked in the emergency department. Other specific laboratory investigations such
as fasting blood glucose, hemoglobin A1C, lipid panel test, thyroid function test,
rheumatologic panel tests, hypercoagulable panel tests, heavy metal tests, homocysteine and
α-galactosidase will be checked on the day after admission, following overnight fasting. For
the genetic test for CADASIL, investigators will ask for a further informed consent. All
patients will undergo cardiac evaluation during the admission period, including 24-hour
Holter monitoring, transthoracic echocardiography and transesophageal echocardiography.
Neuroimaging. Brain imaging studies will be interpreted by more than one neuro-radiologist
at each center without any knowledge of the clinical information. Standardized magnetic
resonance image (MRI) sequences will be recommended to all participating centers. The
minimal requirements for brain imaging studies are diffusion-weighted images, FLAIR images,
T2-weighted images, and gradient echo images. All participants will undergo additional
vascular imaging studies such as CT angiography, MR angiography or digital subtraction
angiography. Based on the neuroimaging, ischemic stroke location, size and vascular
territories will be noted. The diagnosis and treatment of stroke will follow the standard
guidelines of each coordinating center.
Life style questionnaires. After making the baseline measurements, a standardized life style
questionnaire will be provided to all patients who do not have a language problem. Age- and
sex-matched healthy controls will be asked the same questions. The standardized
questionnaire again requests demographic data such as age, gender, height, weight, abdominal
circumference, traditional risk factors, medication history and other comorbidities.
Newly-added demographic data include family history of risk factors, ABO type, marital
status, living status, economic status, educational status and presence of pain and
headache. Marital status is classified as married, single, divorced or widowed. Living
status is classified as alone, with spouse, with family, or with non-family member. Economic
status is classified into five categories (500 USD/month, 500~1500 USD/month, 1500~3000
USD/month, 3000~5000 USD/month and >5000 USD/month) and educational status is classified
into six categories (none, <6 years, 6-9 years, 9-12 years, 12 years, >12 years). Questions
about headaches are mainly focused on migraine: headache character, location, frequency,
duration, aura, aggravating factors, medication history and family history. Only women will
answer questions about obstetric history in terms of age at menarche and menopause (if
participants have experienced them), use of oral contraceptives, history of hormone
replacement therapy, and history of hysterectomy or oophorectomy. Women who have experienced
pregnancy are asked about gravidity, number of children, years of births, mode of delivery,
duration of maternal lactation, and number of miscarriages or abortions.
Lifestyle factors such as alcohol consumption, dietary habits, exercise and sleep patterns
are included in the questions. Alcohol consumption is defined as type of alcoholic drink,
amount per day and date when consumption began. Dietary habits include meal frequency and
consumption of salts, meats, vegetables and 7 types of beverages (coffee, black tea, oolong
tea, green tea, ginseng tea, fruit juice and carbonated beverage) during the past year.
Exercise will be calculated according to the International Physical Activity Questionnaire
(IPAQ), which is a standardized instrument for measuring the amount of exercise.9 Duration
of sleep, sleep latency, frequency of waking-up after sleep onset (WASO), snoring severity,
duration of naps, history of using sleeping pills and length of time in bed without sleeping
will be reported to evaluate sleep patterns. Investigators will also add the validated
Korean version of the Epworth Sleepiness Scale for measuring daytime sleepiness,10 and
questions about restless leg syndrome.
Psychological distress will be analyzed by a composite measure of occupational distress,
perceived stress, and depression. For occupational distress, both occupational status and
job strain will be analyzed. Not only occupation type but also period of service in the
current and previous occupation will be noted to evaluate occupational status. Average daily
working hours, commuting method (car, bus, subway, walk or other) and commuting time (less
than 30 minutes, 30 minutes to 1 hour, 1 hour to 2 hours or more than 2 hours) will also be
recorded. Job strain will be investigated by means of a job content questionnaire (JCQ)
validated in the Korean language.
Perceived stress and depression will be answered on the basis of premorbid status. The
Perceived Stress Scale (PSS) and Center of Epidemiologic Studies Depression scale (CES-D)
Korean version, which have been validated in the relevant fields, will be used to measure
the subjective status of patients and controls.
Statistical analysis. The study will comprise 470 case-control pairs. Means with standard
deviations will be calculated for continuous variables, and numbers with percentages will be
obtained for discrete variables. To assess the relationship between characteristics and
ischemic stroke in young adults, investigators will use paired t-tests for continuous
variables and chi-square tests for proportions. For nonparametric variables, the
Mann-Whitney U test will be used.
Conditional logistic regression analysis will be employed to assess differences between
cases and matched controls by estimating odds ratios (ORs) and 95% confidence intervals
(CIs). Adjusted ORs for risk factors will be derived from multivariable logistic regression
models. These will include all collected variables with possible significance. Kaplan-Meier
survival analysis will be used to estimate cumulative risk of mortality, recurrent vascular
events and post-stroke seizure. Hazard ratios for the previously-mentioned secondary
objectives will be calculated by Cox regression analysis, and assumptions of proportionality
will be confirmed by time-dependent covariate analysis. All the statistical analyses will be
two-sided and will use IBM SPSS 21.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |